4

FORM 4 - DK 10.04.24

Company: Eton Pharmaceuticals, Inc.
Filed: October 4, 2024
Period of Report: October 2, 2024
Accession Number: 0001437749-24-030714

View Document ↗ View on SEC.gov ↗